Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Structural basis for specificity of retroviral proteases.

Wu J, Adomat JM, Ridky TW, Louis JM, Leis J, Harrison RW, Weber IT.

Biochemistry. 1998 Mar 31;37(13):4518-26.

PMID:
9521772
3.

Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.

Cameron CE, Grinde B, Jentoft J, Leis J, Weber IT, Copeland TD, Wlodawer A.

J Biol Chem. 1992 Nov 25;267(33):23735-41.

4.
5.

Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.

Cameron CE, Ridky TW, Shulenin S, Leis J, Weber IT, Copeland T, Wlodawer A, Burstein H, Bizub-Bender D, Skalka AM.

J Biol Chem. 1994 Apr 15;269(15):11170-7.

6.

Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.

Ridky TW, Kikonyogo A, Leis J, Gulnik S, Copeland T, Erickson J, Wlodawer A, Kurinov I, Harrison RW, Weber IT.

Biochemistry. 1998 Sep 29;37(39):13835-45.

PMID:
9753473
7.

Programming the Rous sarcoma virus protease to cleave new substrate sequences.

Ridky TW, Bizub-Bender D, Cameron CE, Weber IT, Wlodawer A, Copeland T, Skalka AM, Leis J.

J Biol Chem. 1996 May 3;271(18):10538-44.

8.

The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.

Mulichak AM, Hui JO, Tomasselli AG, Heinrikson RL, Curry KA, Tomich CS, Thaisrivongs S, Sawyer TK, Watenpaugh KD.

J Biol Chem. 1993 Jun 25;268(18):13103-9.

9.

Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.

Louis JM, Dyda F, Nashed NT, Kimmel AR, Davies DR.

Biochemistry. 1998 Feb 24;37(8):2105-10.

PMID:
9485357
10.

Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.

Kádas J, Weber IT, Bagossi P, Miklóssy G, Boross P, Oroszlan S, Tözsér J.

J Biol Chem. 2004 Jun 25;279(26):27148-57. Epub 2004 Apr 20.

11.

Three-dimensional structures of HIV-1 and SIV protease product complexes.

Rose RB, Craik CS, Douglas NL, Stroud RM.

Biochemistry. 1996 Oct 1;35(39):12933-44.

PMID:
8841139
12.

Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.

Swairjo MA, Towler EM, Debouck C, Abdel-Meguid SS.

Biochemistry. 1998 Aug 4;37(31):10928-36.

PMID:
9692985
13.

Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease.

Li M, Morris GM, Lee T, Laco GS, Wong CH, Olson AJ, Elder JH, Wlodawer A, Gustchina A.

Proteins. 2000 Jan 1;38(1):29-40.

PMID:
10651036
14.

Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.

Tözsér J, Zahuczky G, Bagossi P, Louis JM, Copeland TD, Oroszlan S, Harrison RW, Weber IT.

Eur J Biochem. 2000 Oct;267(20):6287-95.

15.

Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.

Tomaszek TA Jr, Moore ML, Strickler JE, Sanchez RL, Dixon JS, Metcalf BW, Hassell A, Dreyer GB, Brooks I, Debouck C, et al.

Biochemistry. 1992 Oct 27;31(42):10153-68.

PMID:
1420138
16.

Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.

Heaslet H, Lin YC, Tam K, Torbett BE, Elder JH, Stout CD.

Retrovirology. 2007 Jan 9;4:1.

17.
18.

Mutations that alter the activity of the Rous sarcoma virus protease.

Grinde B, Cameron CE, Leis J, Weber IT, Wlodawer A, Burstein H, Bizub D, Skalka AM.

J Biol Chem. 1992 May 15;267(14):9481-90.

19.
20.

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.

Tomasselli AG, Hui JO, Sawyer TK, Staples DJ, Bannow C, Reardon IM, Howe WJ, DeCamp DL, Craik CS, Heinrikson RL.

J Biol Chem. 1990 Aug 25;265(24):14675-83.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk